Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.06, $0.03 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $853 million versus the consensus estimate of $858.61 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.